‘Pharma Bro’ Martin Shkreli Still Banned For Life From Pharmaceutical Industry
ForbesJAN 2024
US Court Upholds Pharma CEO Martin Shkreli's Ban
Image copyright: (2017) Drew Angerer/Getty Images News via Getty Images
The Spin
Pro-establishment narrative
Having infamously raised the cost of a life-saving drug by about 5000%, this latest ruling is absolutely justified. Shkreli exemplifies the kind of greed and inhumanity that plagues the pharmaceutical industry and ultimately, comes to cost the taxpayer. This is a great example of a corporate executive being rightfully held accountable for anticompetitive conduct.
Establishment-critical narrative
Criticism of Shkreli alone misses the egregious reality behind the decisions made at Vyera Pharmaceuticals. Emphasis on individual responsibility can only go so far — the American people should be looking more closely at the fact that anticompetitive and monopolizing moves were possible at all under the current system. At the very least, in a political landscape that rewards supposedly anti-establishment figures, Shkreli is candid in his motivation to exploit failures of the US medical industry.
Anti-Trump narrative
The federal appeals court in New York has made the right decision upholding Martin Shkreli's permanent ban from the pharmaceutical industry. However, the more interesting aspect of the decision is how it impacts Letitia James' case against Donald Trump. The Shkreli ban shows that serial criminals who defraud consumers and investors can be brought to justice — Trump certainly fits that criterion.
Pro-Trump narrative
While the courts can point to Martin Shkreli's infractions, it's ridiculous to imply that Donald Trump could be subjected to a similar ban from New York's real estate industry. Shkreli was a convicted criminal who served several years in prison; however, Trump's only crime is challenging the Democratic establishment. Letitia James is grasping at straws, and her arguments keep getting weaker.